Market Summary - August 19, 2026
Market Overview
On August 19, 2026, the US market experienced a sell-off, particularly in the technology sector, with the Nasdaq 100 index declining by approximately 1.7%. This downturn was largely influenced by significant losses in semiconductor and memory companies, including CoreWeave (-12%), Lumentum (-10%), Seagate, Teradyne, and Sandisk (each -9%).
Despite the initial sell-off, the market opened today with a correction, buoyed by rising oil and gas prices and a response to the US Treasury Department's announcement regarding the expansion of its buyback program. This program aims to enhance liquidity by doubling the maximum threshold for individual buyback operations from $2 billion to $4 billion, focusing on long-term Treasury bonds.
Impact of Treasury Buyback Program
The buyback program is set to commence on September 9 and will remain in effect until at least November 4. This intervention is designed to stabilize the bond market, which has seen rising yields, particularly at the long end of the curve, where 30-year bond yields recently surpassed 5.33%. While this action does not equate to a loosening of monetary policy, it has a similar effect on market sentiment, leading to a notable drop in yields across the curve.
Historically, low bond yields have made stock investments more attractive, a phenomenon referred to as TINA (There Is No Alternative). However, with current yields around 5.3% for 30-year bonds, investors are reevaluating the risks associated with stock market investments.
Technology Sector Sensitivity
Technology companies, especially growth stocks, are particularly sensitive to changes in bond yields. Rising yields increase the discount rate, which diminishes the present value of future cash flows. Additionally, higher Treasury yields often lead to increased borrowing costs for companies, impacting those that require significant capital investments.
Corporate Highlights
Moderna Inc. (MRNA.US)
Moderna's share price surged over 140% following the announcement of positive results from a late-stage trial for a personalized cancer vaccine, which showed improved efficacy in reducing melanoma recurrence when combined with Merck's Keytruda. The CEO indicated potential approval as early as 2027.
Estee Lauder (EL.US)
Estee Lauder's shares rose by 16.7% after reporting better-than-expected quarterly results, with revenues showing positive growth after three disappointing quarters. The company also announced plans to reduce its workforce by nearly 10,000 positions to improve profitability.
Target (TGT.US)
Target's stock increased by 5.9% after exceeding analysts' expectations for comparable sales and adjusted earnings per share in the second quarter. The company raised its earnings forecasts for 2027 significantly.
SK Hynix (SKHY.US)
SK Hynix announced a share buyback plan worth approximately $29 billion, leading to a 3.3% increase in its stock price.